----
Current ValuationThe current P/E ratio is -6.36, within the reasonable range, cheaper than 56.33% of the time in the past 5 years, and the industry ranks 38/53, the industry Median -0.22.
-6.36xP/E
$2.04Stock price
$-0.32Earnings per share
-6.36xP/E
Stock price$2.04Earnings per share$-0.32
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -5.41x
- Typical range
- -11.43x–-3.03x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0285684112
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
SSDOYUSShiseido | -74.29x | -- | $9.74B |
COTYUSCoty | -4.94x | 115.33% | $3.06B |
EPCUSEdgewell Personal Care | -14.67x | 79.87% | $1.37B |
HNSTUSHonest | -39.16x | 166.37% | $476.34M |
USNAUSUSANA Health Sciences | -12.49x | 205.17% | $264.77M |
GLASUSGlass House Brands | -3.79x | -- | $243.15M |
NUSUSNu Skin | -1.12x | 248.43% | $242.90M |
YSGUSYatsen | -6.36x | 34.19% | $191.35M |
MEDUSMedifast | -3.60x | 19.41% | $147.03M |
MLKMFUSWALDENCAST PLC | -0.58x | -- | $96.69M |
SKINUSSkinHealth | -2.53x | 9.29% | $71.90M |
UPXIUSUpexi | -0.22x | -- | $53.46M |
ZIVOUSZivo Bioscience | -5.13x | -- | $43.55M |
BHSTUSBioHarvest Sciences | -2.99x | 12.08% | $33.10M |
HYEXUSHealthy Extracts Inc. | -23.48x | -- | $20.64M |
DQWSUSDSwiss, Inc. | -70.67x | -- | $17.38M |
MTEXUSMannatech | -2.25x | -- | $16.67M |
DSYUSBig Tree Cloud | -- | -- | $15.52M |
GLUCUSGlucose Health, Inc. | -- | -- | $11.23M |
SKTGUSSkyTech Orion Global Corp. | -5.03x | -- | $9.61M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
